Omnicell, Inc. (OMCL) News
Filter OMCL News Items
OMCL News Results
|Loading, please wait...|
OMCL News Highlights
- For OMCL, its 30 day story count is now at 11.
- Over the past 22 days, the trend for OMCL's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- The most mentioned tickers in articles about OMCL are FDS, VIEW and CDNS.
Latest OMCL News From Around the Web
Below are the latest news stories about OMNICELL Inc that investors may wish to consider to help them evaluate OMCL as an investment opportunity.
The number of robotics and automation companies has increased dramatically in recent decades as corporations seek to produce goods and services more efficiently, often replacing more expensive human employees in the process. Examples of companies that offer robotics solutions and products include Cognex Corp. (CGNX), Cadence Design Systems Inc. (CDNS), and U.K.-based Blue Prism Group PLC (PRSM). Robot and automation stocks, as represented by the ROBO Global Robotics and Automation Index ETF (ROBO), have outperformed the broader market.
With the FDS Amplicare acquisition, Omnicell (OMCL) is expected to gain from several healthcare trends, banking on its offerings of digital technologies, SaaS solutions, and tech-enabled services.
MOUNTAIN VIEW, Calif., September 09, 2021--Omnicell Completes Acquisition of FDS Amplicare
Omnicell (OMCL) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Sector ETF report for PSCH
Omnicell, Inc. (OMCL) revealed that it has launched a new software development center in Bangalore, India. The new center will focus on product innovations and advance the company's strategy to deliver the cloud-based infrastructure to support the Autonomous Pharmacy. Shares of the multinational healthcare technology company, with the current market capitalization of around $7 billion, have gained 128% over the past year. (See Omnicell stock charts on TipRanks) Omnicell’s Autonomous Pharmacy replaces error-prone manual systems with intelligent technology and automated workflows by using a robust combination of services delivered through a cloud platform.
Omnicell's (OMCL) new software development center in Bangalore, India, is expected to bolster the company's cloud-based solutions portfolio.
MOUNTAIN VIEW, Calif., September 07, 2021--Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced it has opened a new software development center via its India subsidiary based in Bangalore, India. Omnicell’s new center will focus on product innovations to advance the Company’s strategy to deliver the cloud-based infrastructure to support the Autonomous Pharmacy.
While Omnicell, Inc. ( NASDAQ:OMCL ) might not be the most widely known stock at the moment, it saw a double-digit...
Recent market volatility has created several unique buying opportunities for savvy investors with long-term time horizons.